Sustained high levels of serum interferon-γ during HIV-1 Infection: A specific trend different from other cytokines

Viral Immunology

Volumn 23, Issue 6, 2010, Pages 619-625

  Watanabe, Dai ^a   Uehira, Tomoko ^a   Yonemoto, Hitoshi ^a   Bando, Hiroki ^a   Ogawa, Yoshihiko ^a   Yajima, Keishiro ^a   Taniguchi, Tomohiro ^a   Kasai, Daisuke ^a   Nishida, Yasuharu ^a   Shirasaka, Takuma ^a  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 7; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; JAPANESE; LONGITUDINAL STUDY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIAN CONTINENTAL ANCESTRY GROUP; CROSS-SECTIONAL STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78650165537     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0065     Document Type: Article

References (25)

1. Alonso K, Pontiggia P, Medenica R, and Rizzo S: Cytokine patterns in adults with AIDS. Immunol Invest 1997;26:341-350.
2. Ameglio, F., Cordiali Fei P, Solmone M, et al.: Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages. J Biol Regul Homeost Agents 1994;8:48-52.
3. Aziz N, Nishanian P, and Fahey JL: Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures. Clin Diagn Lab Immunol 1998;5:755-761.
4. Breen EC, Rezai AR, et al.: Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990; 144:480-484.
5. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, and Shearer GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993;91:759-765.
6. Clerici M, and Shearer GM: The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994;15:575-581. (Pubitemid 24353909)
7. Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, and Shearer GM: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4\+ cell numbers and clinical staging. J Clin Invest 1989; 84:1892-1899.
8. Greco G, Fujimura SH, Mourich DV, and Levy JA: Differential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation. J Virol 1999;73:1528-1534.
9. Iannello A, Boulassel MR, Samarani S, et al.: Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study. J Immunol 2010;184:114-126.
10. Iannello A, Tremblay C, Routy JP, Boulassel MR, Toma E, and Ahmad A: Decreased levels of circulating IL-21 in HIV-infected AIDS patients: correlation with CD4\+ T-cell counts. Viral Immunol 2008;21:385-388.
11. Kedzierska K, and Crowe SM: Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother 2001;12:133-150.
12. Kishimoto T, Akira S, and Taga T: Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992;258:593-597.
13. Levy Y, Lacabaratz C, Weiss L, et al.: Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest 2009;119:997-1007.
14. Llano A, Barretina J, Gutierrez A, Blanco J, Cabrera C, Clotet B, and Este JA: Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J Virol 2001;75:10319-10325.
15. Napolitano LA, Grant RM, Deeks SG, et al.: Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001; 7:73-79.
16. Orsilles MA, Pieri E, Cooke P, and Caula C: IL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapy. APMIS 2006;114:55-60.
17. Rosenberg SA, Sportes C, Ahmadzadeh M, et al.: IL-7 administration to humans leads to expansion of CD8\+ and CD4\+ cells but a relative decrease of CD4\+ T-regulatory cells. J Immunother 2006;29:313-319.
18. Scott-Algara D, Vuillier F, Marasescu M, de Saint Martin J, and Dighiero G: Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients. AIDS Res Hum Retroviruses 1991;7:381-386.
19. Sereti I, Dunham RM, Spritzler J, et al.: IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 2009;113:6304-6314.
20. Shelburne SA, Montes M, and Hamill RJ: Immune re-constitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 2006;57:167-170.
21. Streeck H, Frahm N, and Walker BD: The role of IFN-gamma Elispot assay in HIV vaccine research. Nat Protoc 2009;4:461-469.
22. Stylianou E, Aukrust P, Kvale D, Muller F, and Froland SS: IL-10 in HIV infection: increasing serum IL-10 levels with disease progression\down- regulatory effect of potent anti-retroviral therapy. Clin Exp Immunol 1999;116:115-120.
23. Stylianou E, Bjerkeli V, Yndestad A, et al.: Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients. Clin Exp Immunol 2003 132:462-466.
24. Surh CD, and Sprent J: Homeostasis of naive and memory T cells. Immunity 2008;29:848-862.
25. Torre D, Speranza F, Martegani R, Pugliese A, Castelli F, Basilico C, and Biondi G: Circulating levels of IL-18 in adult and paediatric patients with HIV-1 infection. AIDS 2000; 14:2211-2212.